We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRU:NYSEPrudential Financial, Inc. Analysis

Data as of 2026-05-19 - not real-time

$101.51

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Prudential Financial is trading at $101.51, comfortably above its 20‑day (≈$99.15) and 50‑day (≈$97.35) SMAs but still below the 200‑day SMA (≈$104.34), signaling a short‑term bullish bias within a longer‑term neutral framework. The MACD histogram is positive (≈0.29) and the MACD line sits above its signal, reinforcing the near‑term upside momentum, while the RSI at 56 % suggests the stock is not overbought. Valuation metrics are attractive: the trailing P/E of ~10.5 is well under the industry average of 16.5, and the price‑to‑book ratio of ~1.09 hovers near book value, indicating the market may be undervaluing the balance sheet. A dividend yield of 5.44 % with a payout ratio of 56 % is supported by robust free cash flow of $10.4 B, pointing to dividend sustainability. However, the company carries a high debt‑to‑equity ratio of ~159, and recent analyst downgrades from Morgan Stanley and Barclays to underweight reflect concerns over leverage and earnings stability. Volume trends are decreasing and 30‑day volatility is elevated at ~25 %, adding short‑term price uncertainty. The Fear & Greed Index reads “Extreme Greed,” suggesting market optimism may be overstated. Overall, the stock appears fairly valued with modest upside potential (~1 % downside per the DCF model) and a strong income component, but investors should weigh the leverage and recent negative sentiment.
Given these dynamics, a cautious stance is warranted: hold the position to capture the dividend while monitoring the leverage profile and any further rating changes, with a view to adjust if the price breaches the $104 resistance or falls toward the $92 support.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above short‑term SMAs
  • Recent analyst downgrades and decreasing volume
  • High dividend yield with sustainable payout

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Valuation metrics (low P/E, near‑book P/B) suggest value appeal
  • Strong free cash flow supporting dividend continuity
  • Elevated leverage requiring monitoring

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive dividend yield and payout ratio
  • Undervalued relative to industry peers
  • Stable earnings from diversified insurance and investment segments

Key Metrics & Analysis

Financial Health

Revenue Growth15.30%
Profit Margin5.48%
P/E Ratio10.5
ROE10.71%
ROA0.41%
Debt/Equity158.97
P/B Ratio1.1
Op. Cash Flow$9.8B
Free Cash Flow$10.4B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI56.2
Support$92.66
Resistance$104.11
MA 20$99.15
MA 50$97.35
MA 200$104.34
MACDBullish
VolumeDecreasing
Fear & Greed Index89.3

Valuation

Fair Value$682.89
Target Price$100.47
Upside/Downside-1.03%
GradeFair
TypeValue
Dividend Yield5.44%

Risk Assessment

Beta0.96
Volatility25.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.